Parkinson’s Disease PBMC

In Stock Samples

Lot Number Condition Cell Count (M) Race/Ethnicity Age Gender Country of Collection Medications Vials Price Action
73016 Parkinson's Disease 10M Caucasian 75 Male
Repatha® (evolocumab) /140mg/every 2 weeks Finasteride /5mg/QD Alfuzosin/10mg/QD Pantoprazole/40mg/PRN Baclofen 5 mg QD- No longer taking
6
72955 Parkinson's Disease 10M Caucasian 78 Male
Extended release Carbidopa / Levodopa/2500mg/QID Tamsulosin/0.4mg/QD SAW PALMETTO/450mg/QD VIt D QW Vit C
6
73019 Parkinson's Disease 10M Caucasian 70 Female
Carbidopa/Levodopa 25/100 IR 10 tabs po QD Carbidopa/Levodopa 25/100 ER 2 tabs po QHS Selegiline 5 mg po QD Paroxetine HCL 30 mg po QD Levothyroxine 0.75 mcg po QD Fluocinolone Acetonide Cream QD Fluocinonide Topical solution PRN Restasis BID Clobetasol Propionate Cream Weekly Vitamin D3 2000 IU po QD Multivitamin po QD Melatonin 10 mg Tylenol PRN
4
69267 Parkinson's Disease 10M Caucasian 71 Male
Rosuvastatin 10 mg QD Cyclobenzaprine 5 mg TID PRN Indonethacin 50 mg BID Carbidopa/Levidopa 8 tabs per day Donepezil 5 mg QD Glycopyrrolate 1 mg TID PRN Entacapone 200 mg QD Vit D QW Levothyroxine 125 mcg QD Ciclopirox PRN
3
78428 Parkinson's Disease 10M Male
Acetylsalicylic acid, Bisoprolol, Carbidopa/levodopa
1
78429 Parkinson's Disease 10M Male
Acetylsalicylic acid, Bisoprolol, Carbidopa/levodopa
1
78430 Parkinson's Disease 10M Male
Acetylsalicylic acid, Bisoprolol, Carbidopa/levodopa
1
78431 Parkinson's Disease 10M Male
Acetylsalicylic acid, Bisoprolol, Carbidopa/levodopa
1
78432 Parkinson's Disease 10M Male
Acetylsalicylic acid, Bisoprolol, Carbidopa/levodopa
1
78361 Parkinson's Disease 10M Male
Acetylsalicylic acid, Carbidopa/levodopa
1

High-Quality Parkinson’s Disease PBMC for Research

Parkinson’s Disease Human PBMC products are sourced from donors clinically diagnosed with Parkinson’s Disease and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on immune profiling, immune response, and gene expression patterns associated with disease progression.

Product Features

  • Research Use Only (RUO), cryopreserved PBMCs
  • Clinically confirmed Parkinson’s Disease donors
  • Available in cell counts ranging from 5 million to 2 billion
  • Processed within 24 hours of collection
  • Stored using CryoStor® CS10 freezing media
  • IRB-approved protocols and electronic informed consent
  • Screen LeukoLot™ available prior to bulk orders

De-identified Donor Data

  • Verified Parkinson’s Disease diagnosis
  • Donor demographics: age, sex assigned at birth, race/ethnicity
  • Self-reported allergies and infectious disease history
  • Additional Parkinson’s Disease-specific data available upon request

Applications

  • Biomarker discovery and validation
  • Drug screening and therapeutic development
  • Immune pathway analysis in Parkinson’s Disease pathophysiology
  • Transcriptomic and proteomic profiling

Quality and Compliance

  • IRB-approved collections and protocols
  • 21 CFR Part 11 – compliant e-consent system
  • HIPAA-compliant donor data protection

Ordering & Shipping

Parkinson’s Disease PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Frequently Asked Questions

Showing 13–24 of 30 results

Do samples come with donor screening reports?

1 Answer

All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/

YES – Certificate of analysis is available upon request.

Lead times vary from ready to ship inventory to prospective studies.

International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.

We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/

You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/

NO – no minimum order requirements.

For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com

YES – Fresh leukopaks can be delivered same day in select locations. Often, leukopaks are shipped same day as collection, thus arriving next day.

Contact learnmore@sanguinebio.com for current inventory. The website states “over 150 verified-conditions from ready-to-ship to prospective collections.” View our ready to ship products: https://sanguinebio.com/products/?pro_inventory=inventory

YES – Matched samples across multiple matrices are available, including synovial fluid are available.

1 2 3
×

Ask a Question

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information